Back to results
US 6,727,274 B2Granted
Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
AssigneePharmacia & Upjohn Company
InventorJian-Min Fu
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of formula I for use in treating conditions in which 5-HT6 receptors are involved such as in anxiety, depression, schizophrenia, Alzheimer's disease, stress-related disease, panic, a phobia, obsessive compulsive disorder, obesity, post-traumatic stress syndrome, epilepsy, and other CNS disorders.
Claims29
A compound of formula I
- wherein
- - - - [b] is a single or double bond;
- Each X, Y, and Z is independently selected from H, —OH, —O-alkyl, and —O-substituted alkyl;
- R1 is selected from H, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, and aryl;
- R2 is selected from H, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, and aryl;
- R3 is selected from H, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl;
- Each R4, R5, R6, and R7 is independently selected from H, halogen, aryl, —CN, —NO2, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, and —S(O)naryl, provided that one of R4, R5, R6, and R7 is —S(O)naryl, and that at least one of R4, R5, R6, and R7 is H;
- n is 0, 1, or 2;
- and pharmaceutically acceptable salts thereof.
6 more elements
Dependencies are inferred from the claim text.